Search results
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane , which became known for its efficacy against lung, breast, and pancreatic cancer .
Dr. Patrick Soon-Shiong. Executive Chairman and Global Chief Scientific and Medical Officer at ImmunityBio. That fascination led him on the path to a distinguished career as a surgeon, scientist, inventor, and philanthropist with over 500 issued worldwide patents and 100 scientific publications. In 2001, Dr.
Jun 3, 2024 · Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold his drug companies Abraxis in 2010 and...
Oct 25, 2021 · Today, at sixty-nine, Patrick Soon-Shiong is worth at least eight billion dollars. He has been called the richest man in Los Angeles; he is one of the richest doctors in the world.
Apr 13, 2018 · Dr. Patrick Soon-Shiong, a former UCLA transplant surgeon and now a billionaire biotech entrepreneur, is buying the Los Angeles Times.
Jun 22, 2018 · Patrick Soon-Shiong, MD, is the executive chairman of the Los Angeles Times. A physician, surgeon, scientist, inventor, technologist and philanthropist, Dr. Soon-Shiong has devoted his career...
4 days ago · Soon-Shiong topped the Business Journal’s 2023 list of Wealthiest Angelenos with a net worth of $19.1 billion. His other major venture is the El Segundo-based publishing company for the Los ...
3 days ago · Overview. Soon-Shiong became a billionaire after selling two drug companies: APP Pharmaceuticals and Abraxis BioScience. He sold APP to Fresenius Medical Care for $4.6 billion in 2008, and...
Soon-Shiong has developed multiple medical and scientific firsts in the fields of diabetes and cancer: the first encapsulated islet cell transplant in man, the first pig to man insulin cell transplant, and the world's first human protein nanoparticle approved for breast, lung, and pancreatic cancer.
Soon-Shiong performed the world’s first encapsulated human islet transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer, doubling the response rate in patients.
Related searches
